NCT05522387Phase 2Terminated

An Open-Label Extension of XPro1595 in Patients With Alzheimer's Disease

Study sponsor: Inmune Bio, Inc. · INMB

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2024-06-05Actual
Enrollment · participants11Actual
Source updated2026-02-27Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Recruitment status changed

Before: Active not recruiting. After: Terminated.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview